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ABSTRACT
The Gene Ontology (GO) is a comprehensive re-
source of computable knowledge regarding the func-
tions of genes and gene products. As such, it is ex-
tensively used by the biomedical research commu-
nity for the analysis of -omics and related data. Our
continued focus is on improving the quality and util-
ity of the GO resources, and we welcome and encour-
age input from researchers in all areas of biology. In
this update, we summarize the current contents of
the GO knowledgebase, and present several new fea-
tures and improvements that have been made to the
ontology, the annotations and the tools. Among the
highlights are 1) developments that facilitate access
to, and application of, the GO knowledgebase, and
2) extensions to the resource as well as increasing
support for descriptions of causal models of biologi-
cal systems and network biology. To learn more, visit
http://geneontology.org/.
INTRODUCTION
Because of the staggering complexity of biological systems
and the ever-increasing size of datasets to analyze, biomed-
ical research is becoming increasingly dependent on knowl-
edge stored in computable form. The Gene Ontology (GO)
project provides the most comprehensive resource currently
available for computable knowledge regarding the func-
tions of genes and gene products. The GO knowledgebase
is composed of two primary components. The first is the
Gene Ontology (GO), which provides the logical structure
of the biological functions (‘terms’) and their relationships
to one another, manifested as a directed acyclic graph. The
second is the corpus of GO annotations, evidence-based
statements relating a specific gene product (a protein, non-
coding RNA, or macromolecular complex, which we re-
fer to hereafter as ‘genes’ for simplicity) to a specific on-
tology term. Crucially, each annotation is linked to the
evidence supporting that biological conclusion, typically
a specific publication from the biomedical literature. To-
gether, the ontology and annotations aim to describe a
comprehensive model of biological systems. Currently, the
GO knowledgebase includes experimental findings from al-
most 140 000 published papers, represented as over 600 000
experimentally-supported GO annotations. These provide
the core dataset for additional inference of over 6 million
functional annotations for a diverse set of organisms span-
ning the tree of life.
In addition to this core knowledgebase, GOC resources
also include software to edit and perform logical reasoning
over the ontologies, web access to the ontology and annota-
tions, and analytical tools that use the GO knowledgebase
to support biomedical research.
Here, we describe new developments in the last two years,
including improvements in the ontology, increases in the
number of GO annotations, and enhancements to make
it easier for users to obtain and properly apply the infor-
mation in the GO knowledgebase. The GO and associated
products are available under a Creative Commons Attribu-
tion license from http://geneontology.org.
EXPANSION OF THE GO KNOWLEDGEBASE
Ontology
The Gene Ontology defines the universe of concepts relat-
ing to gene functions (‘GO terms’), and how these functions
are related to each other (‘relations’). It is constantly re-
vised and expanded as biological knowledge accumulates.
Table 1 shows the number of terms and relations currently
comprising the GO, which continues to increase compared
to our last update two years ago (1). The GO describes
function with respect to three aspects: molecular function
(molecular-level activities performed by gene products), cel-
lular component (the locations relative to cellular struc-
tures in which a gene product performs a function), and
biological process (the larger processes, or ‘biological pro-
grams’ accomplished by multiple molecular activities). On-
going revisions to the ontology are managed by a team of
senior ontology editors with extensive experience in both bi-
ology and computational knowledge representation. Ontol-
ogy updates are made collaboratively between the GOC on-
tology teamand scientists who request the updates.Most re-
quests come from scientists making GO annotations (these
typically impact only a few terms each), and from domain
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experts in particular areas of biology (these typically revise
an entire ‘branch’ of the ontology comprising many terms
and relations).We invite researchers and computational sci-
entists to submit requests for either new terms or new rela-
tions in the ontology.
New ontology terms may be requested in two ways, ei-
ther semi-manually via the online, templated form known
as TermGenie (2) or manually, via a GitHub tracker (https:
//github.com/geneontology/go-ontology/issues). Using the
online TermGenie interface, submitted templated terms are
screened by senior ontology editors for approval. In most
cases, terms are approved as-is, but the tool also allowsman-
ual editing to correct occasional typographical errors, logi-
cal construction of definitions, or obsoletion of terms when
deemed inappropriate.
Requests via the GitHub tracker may also include
changes to the structure of the ontology and new rela-
tionships types. As with TermGenie, requests are manu-
ally reviewed by ontology editors who conduct the appro-
priate survey of the literature to validate or reject the re-
quest. Often the ontology revision process includes a dia-
logue between the submitter and the ontology editor, and
for more complex cases, within the larger ontology devel-
opment group, with the members of the annotation team,
and with experts in specific areas of biology. This process
ensures accurate representation of the biology. Written dis-
cussions are audited through the GitHub issue tracking
mechanism and guidelines for submitting new requests are
posted here: https://github.com/geneontology/go-ontology/
blob/master/CONTRIBUTING.md.
Logical definitions and inter-ontology links. Axioms are an
important component of any ontology. They are used to
define the relationships that any given class has with re-
gards to other classes in the ontology. They are essential
for supporting computational reasoning over the GO, and
for maintenance of the complex logical structure of the
GO. Ontology editors define new terms with axioms, and
check the corresponding inferences of relations to other
terms, so that the GO remains logically consistent. In our
last update (1), we reported on the go-plus edition of GO,
which includes OWL (Web Ontology Language) equiva-
lence axioms connecting GO to external Open Biomedical
Ontology (OBO) classes (see http://geneontology.org/page/
download-ontology). These axioms allow us to automat-
ically construct and validate large portions of the ontol-
ogy, using knowledge of the relationships between classes
extracted from these external ontologies (see (3) for full
details). In our last update from 2014, there were 9304
inter-ontology links to eightOBO (OpenBiological Ontolo-
gies) sources: CHEBI (chemicals), CL (cell types), PATO
(qualities/descriptors), PO (plant anatomy), PR (proteins),
SO (nucleic acid and protein sequence types), UBERON
(animal anatomy) and OBA (traits). In the 2016-08-08 re-
lease ofGO, the number of links has increased by over a fac-
tor of two, to 21 077 inter-ontology links. This now also in-
cludes links to an additional ontology, the Fungal Anatomy
Ontology (FAO), thereby increasing GO’s interconnection
with descriptions of the biology of the fungal clade.
Domain-focused ontology development. We carried out co-
ordinated ontology development and focused annotation in
several domains of biological function. Neurexins and neu-
roligins, proteins involved in synaptogenesis and known to
be associated with autism spectrum disorder, were the ob-
ject of a focused annotation approach, and descriptive GO
terms were created to better annotate the roles of these gene
products (4). Also, the cellular component ontology was
revised to increase and improve classes to represent extra-
cellular RNA metadata, such as extracellular vesicles (5).
The ExoCarta and Vesiclepedia databases (6,7) have started
to use the revised ontology, and are collaborating with the
GOC to include their annotations in the GO database.
In another specific domain-focused ontology development
and annotation effort, representation of cilia-related biol-
ogywithin theGO resource is currently nearing completion.
While the first part of the project focused on ciliary sub-
components, more recently we worked with experts in the
field towards a better representation of cilia types and bio-
logical processes relevant to the functions of these impor-
tant organelles (manuscripts in preparation). In addition, a
focused curation of cilia-related gene annotations was un-
dertaken. Lastly, we have added over 300 terms describ-
ing plant enzyme molecular functions (with associated En-
zyme Commission identifiers), in response to requests from
a group of plant biologists. We have also begun to design a
representation of biochemical pathways in GO. Beginning
with glycolysis, we devised a strategy for defining pathways
using combinations of necessary enzymatic activities that
are executed as part of the various types of glycolytic path-
ways and chemicals that are used and created by them (8).
We will continue to use this approach for other biochemical
pathways and extend it to define signaling pathways.
GO annotations
GO annotations consist of an association between a gene
and a GO term, with supporting evidence in the form of
a GO ‘evidence code’ and either a published reference or
description of the methodology used to create the anno-
tation. All GO annotations, however, are ultimately sup-
ported by the scientific literature, either directly or indi-
rectly. The GO evidence codes describe the evidence and
roughly reflect how far removed the annotated assertion
is from direct experimental evidence, and whether this ev-
idence was reviewed by an expert biocurator. The number
of GO annotations, for selected evidence codes and differ-
ent aspects of the GO, is shown in Table 2.
Experimentally-supported annotations. The EXPerimen-
tal (EXP) evidence codes indicate that there is evidence
from an experiment directly supporting the annotation of
the gene. For example, an association between a gene prod-
uct and its subcellular localization as determined by im-
munofluorescence would be supported by the Inferred from
Direct Assay (IDA) evidence code, a subtype of EXP ev-
idence. Annotations with direct experimental evidence are
created by biocurators, PhD-level experts trained in compu-
tational knowledge representation, who read peer-reviewed
literature and create GO annotations as justified by the ev-
idence presented in those articles.
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Table 1. Number of terms and relationships in the three aspects of the Gene Ontology, as of October 2016
Aspect Terms (classes) Relationships
Molecular function (MF) 10 417 14 039
Cellular component (CC) 4022 7854
Biological process (BP) 29 146 71 372


















Human 32 369 23 811 5892 36 555 8508 38 819 14 596
Mouse 8740 12 934 7914 22 593 11 336 59 517 18 128
Rat 4239 11 986 6704 15 047 9804 27 591 16 810
Zebrafish 392 1521 6732 937 9845 18 004 17 001
Fruit fly 1137 4965 3168 10 488 4371 30 560 5913
Nematode
(C. elegans)
2649 2203 3386 4858 4983 11 679 7683
Slime mold
(D. discoideum)
521 942 2386 2109 3098 3630 4637
Budding yeast 106 8264 2002 16 752 2753 17 646 3608
Fission yeast 1364 3275 1750 11 290 2526 5074 3257
A. thaliana,
plant
6131 7288 5662 23 762 7375 22 595 11 167
E. coli 2290 5017 734 3911 610 5501 905
To ensure consistency and quality in expert curation
practices, GOC biocurators meet regularly to discuss cu-
ration issues and participate in annotation consistency ex-
ercises. During these exercises, multiple groups of curators
annotate a single paper, which leads to clarification on the
use of ontology terms andGO evidence codes, and develops
best practices and consistency among the distributed GO
annotation groups. For example, clarifying how the results
of co-transfection and functional complementation experi-
ments should be annotated, ensures that information based
on functional genetic interactions versus phenotypic rescue
is unambiguously captured in the GO knowledgebase.
Until recently microRNAs were under-annotated in GO
because microRNA regulation of developmental and cel-
lular processes was a relatively new field of study. Conse-
quently, researchers had to rely on the functional annota-
tions of the microRNA targets as a proxy, because direct
functional annotation of the microRNAs themselves did
not exist. In consultation with experts in the field of mi-
croRNA research, substantial effort was dedicated to re-
dress this situation. We created annotation guidelines for
microRNA annotation (9) and following these guidelines,
we have generated annotations for over 300 humanmicroR-
NAs, 70 inDrosophila melanogaster, and almost 200 inAra-
bidopsis thaliana.
Protein binding annotations are only useful if they in-
clude the specific protein binding partner.With the addition
of the IntAct database (10) as a GO annotation provider,
the number of specific protein binding annotations has in-
creased dramatically (Table 2, first column). Only high-
confidence annotations are incorporated into GO from In-
tAct. Combined with annotations from hypothesis-driven,
small-scale experiments that have been contributed to GO
from multiple different annotation providers, IntAct anno-
tations help make the GO knowledgebase a useful resource
for high-confidence protein interaction network data. To
create protein interaction networks, users need to utilize the
‘with’ field (column 8) of the GO Association Files (GAF),
which contains the identifier of the interacting partner.
We ask users to be aware of annotations that state that a
particular gene product has been foundNOT to have a given
function. The NOT annotation is generally created when a
gene product with specific domain or gene family associa-
tion is expected by inference to have a certain activity, but
where there is explicit experimental data shows that the gene
product does NOT have that activity. These annotations are
relatively rare in the GO knowledgebase (currently there are
∼3300 of these, based on experimental evidence). However,
we believe they may be particularly useful in some applica-
tions, such as assessing function prediction accuracy. These
annotations have the qualifier ‘NOT’ in the qualifier field
(column 4) of the GAF.
Phylogenetically-inferred annotations. Phylogenetic prin-
ciples, reconstructing evolutionary events to infer relation-
ships among genes, provide a powerful way to gain insight
into gene function. The GOC has supported a dedicated
Phylogenetic Annotation effort since 2008 (11), which has
been expanded in the past couple of years. The Phyloge-
netic Annotation method is described in detail elsewhere
(12). Briefly, we have developed software (PAINT, Phyloge-
netic Annotation Inference Tool) with which a biocurator
can view all experimental annotations for genes in a gene
family, and use this information to infer annotations for un-
characterized members of the family. The biocurator cre-
ates an explicit model of gain and loss of gene function at
specific branches in a phylogenetic tree of the family. This
model is used to infer new annotations (i.e. not overlapping
with experimental annotations) for genes in the family. Phy-
logenetically based annotations are denoted by the IBA (In-
ferred from Biological Ancestry) evidence codes. Each in-
ferred annotation can be traced to the direct experimental
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annotations that were used as the basis for that assertion.
The GO Phylogenetic Annotation project is now the largest
source of manually reviewed annotations in the GO knowl-
edgebase, and it has substantially increased the number of
annotations even in organisms that have been well-studied
experimentally (Table 2).
Computationally-inferred annotations. Finally, those fur-
thest removed from direct experimental findings, are the
‘electronic’ (IEA) evidence codes, which are not individually
reviewed (although an extensive manual review of a sample
is generally involved). IEA-supported annotations are ulti-
mately based on either homology and/or other experimen-
tal or sequence information, but cannot generally be traced
to the experimental source. Three methods make up the
bulk of these annotations. The first, and most comprehen-
sive, method is InterPro2GO (13), which is based on the cu-
rated association of a GO term with a generalized sequence
model (‘signature’) of a group of homologous proteins. Pro-
tein sequences with a statistically significant match to a sig-
nature are assigned the GO terms associated with the sig-
nature, a form of homology inference. A second method is
the computational conversion of UniProt controlled vocab-
ulary terms (mostly Enzyme Commission numbers describ-
ing enzymatic activities, and UniProt keywords describing
subcellular locations), to associated GO terms. Lastly, an-
notations are made based on 1:1 orthologs inferred from
Ensembl gene trees, an approachwhich automatically trans-
fers annotations found experimentally in one gene, to its 1:1
orthologs in the same taxonomic clade (e.g. those within
the vertebrate clade, and separately, those within the plant
clade).
USABILITY ENHANCEMENTS
Gene-centric GO annotation sets
Historically, the GOC has allowed each annotation
provider to decide on the set of objects (instantiated as
database identifiers) that are associated with GO terms by
that provider. As a result, there has been some variabil-
ity between different groups, with some providers annotat-
ing genes, some annotating proteins or non-coding RNA’s,
some annotating protein complexes, and some annotating
multiple different types. This is our intended approach, as
we wish to annotate the functions for all macromolecular
machines. However, if multiple different identifiers are ac-
tually referring to the same gene or protein, this can lead to
possible mistakes in analyses that rely on GO annotations.
For example, consumers of GO annotations might count
the same gene multiple times in their analyses if identifiers
are not resolved to a single non-redundant set.
To ensure that each of the GO annotations uses only a
single identifier for any given protein-coding gene, we now
adopt a single, standard identifier for each gene. For well-
studiedmodel organisms that have a dedicated resource, the
primary gene identifier from that resource is used. This has
been the standard for some time, but not consistently em-
ployed by some annotation groups. For other organisms, we
use the protein identifiers from the ‘gene-centric reference
proteome’ (GCRP) sets from the UniProt resource. We col-
laborate with UniProt (14) and the Quest for Orthologs Ini-
tiative (15,16) to develop andmaintain a GCRP set for each
organism across a wide phylogenetic spread. The team at
the UniProt resource generates the GCRP set by selecting a
single ‘reference’ protein entry for each protein-coding gene
in a genome. We are also working with these groups toward
complete consistency between the GCRP sets in UniProt,
and the dedicated model organism resources.
As always, additional information about the annotated
entity (e.g. a specific isoform or modified form), when avail-
able, is recorded in a different column of the GAF. An-
notations directly to macromolecular complexes are pro-
vided in separate files to avoid confusion with annotations
to genes. To ensure completeness for gene-based analyses,
the GO annotations for the genes encoding individual com-
plex members are also included in the gene-centric anno-
tation file. In the gene-centric file, each member of a com-
plex is annotated with the functions of the entire complex
when appropriate (these are flagged with the contributes to
qualifier, see http://geneontology.org/page/go-annotation-
conventions#contri for more details).
Exploring the gene ontology and annotations using AmiGO
2
Since our last update, we have implemented a number of
new features and usability improvements toAmiGO2 (http:
//amigo.geneontology.org/) to facilitate how the community
explores and uses GO. AmiGO 2 now has an interactive on-
tology and annotation browser. This allows users to navi-
gate the GO structure by drilling down from more general
to more specific classes and retrieve filtered annotations to
any branch of the ontology. Annotation retrieval has also
been improved. Whereas in the previous version downloads
were limited to 10,000 lines, one can now download up to
100,000 lines. The addition of these two functionalities al-
lows users to download large, highly customized sets of GO
annotations using the integrated faceting capabilities, in-
cluding taxon and evidence subsets, and free-text searching.
Other highlights include: (i) an integrated PubMed
ID search that retrieves both annotations and interme-
diary PubMed information pages (see below); (ii) a new
Matrix Tool that allows users to explore the overlaps
between gene sets annotated to different GO classes
(http://amigo.geneontology.org/matrix#order); (iii) new
integration capabilities to connect the GO resources into
customized workflows via a public bookmarking API and
Galaxy (17); a Solr (https://cwiki.apache.org/confluence/
display/solr/Apache+Solr+Reference+Guide) document
store search environment which offers more powerful
means to query the GO data; and (v) much improved inte-
grated and interactive statistics and graphics summarizing
the entirety of the GO annotations.
Gene set enrichment analysis
The gene set enrichment analysis tool on the GO homepage
now links directly to the interface at the PANTHERwebsite
(http://go.pantherdb.org/). This enables users to take advan-
tage of the PANTHER visualization tools, such as the new
hierarchical view that organizes enrichment analysis results
using the relations in the GO (18). This view groups re-
lated terms together to facilitate biological interpretation
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Figure 1. GO PubMed article page. All GO annotations that cite the article as evidence are shown on the page (table in lower right). Summary information
on the article is obtained from NCBI web services (upper panel). Lower left panel shows general AmiGO2 filtering functionality: clicking on any of the
data types (e.g. Ontology (aspect)) will allow selection of filters to apply.
Figure 2. LEGO connects annotations. (A) Conventional annotations for
two genes, and (B) the same annotations connected together in a LEGO
model. This example shows ‘The activity of BFA1 (in spindle pole body)
inhibits the GTPase activity of TEM1, as part-of exit from mitosis.’ Addi-
tional context, e.g. cell type, etc. can be added (not shown). Curated from
data in (22).
of the enrichment results. In addition, recent studies have
shown that many enrichment tools use outdated versions
of the ontology or annotations, strongly impacting analy-
ses (19). The GO annotations in PANTHER are updated
monthly. The tool also displays key analysis parameters,
such as GO annotation date/version and analysis tool ver-
sion, that should be reported upon publication to aid in re-
producibility.
Representing PubMed articles on the GO website
The GOC has now integrated a PubMed ID search, which
generates a page for each PubMed (20) article that was used
as evidence to supportGOannotations (Figure 1). The page
lists all GO annotations that were made using experimen-
tal evidence published in that paper. PubMed pages can be
accessed from gene annotation data searches on the GO
website. For example, one can enter a PubMed identifier
(not including the ‘PMID’ prefix) in the ‘Search GO data’
box on the homepage, or click on the ‘Filter and down-
load’ link in the ‘Annotations’ box. Clicking on a PubMed
identifier in the ‘Reference’ column in the annotation re-
sults table directs users to the selected GO PubMed arti-
cle page. The GO annotations comprise a high-level sum-
mary of the findings of a published paper with respect to
gene functions. We expect that authors of papers may also
find these pages very useful to assess how their work has
been represented in the GO knowledgebase, and to provide
feedback on how this representation might be improved.
We have worked with the team at NCBI LinkOut (https:
//www.ncbi.nlm.nih.gov/books/NBK3805/) to include links
fromPubMed records directing users back to theseGOarti-
cle pages. These links allow users to access GO annotations
while searching PubMed.
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FUTURE DIRECTIONS
From annotations to models of biology (LEGO)
The GO annotation structure is historically quite simple, a
statement consisting of one gene and one GO term (along
with the evidence for that association, as described above).
Because gene function is complex, and relates to larger sys-
tems and biological ‘programs’ carried out by multiple gene
products, a typical GO annotation therefore represents just
a single aspect of that function. Previously we reported on
a simple extension to the GO annotation model, called ‘an-
notation extensions’ (21) that allows biocurators to capture
additional contextual information using defined relations
and entities to modify the selected GO term.
However, in order to allow more comprehensive, accu-
rate statements about gene function and howmultiple genes
may function together, we have developed a ‘grammar’ for
combining traditionalGOannotations together into amore
fully integrated representation of how gene functions relate
to each other and to larger biological processes. We call this
new formalism Linked Expressions using the Gene Ontol-
ogy, or LEGO. An initial announcement can be found on
http://geneontology.org/article/gaf-gpad-and-lego.
The LEGO formalism will be described in a separate
publication, but briefly, it defines how different traditional
GO annotations can be combined into a larger ‘model’ of
gene and system function. A simple example is shown in
Figure 2. Importantly, the larger model can and will be
computationally decomposed into traditional GO annota-
tions, so all the current applications of GO annotations,
such as enrichment analysis, will still be supported. How-
ever, we also encourage developers of network-based analy-
sis tools to download the native OWL (Web Ontology Lan-
guage) representation of each LEGO model, that specifies
how the functions of different gene products are linked into
causal networks. Users may also be interested in brows-
ing and viewing published models, which are available at:
http://noctua.berkeleybop.org.
We have developed a software platform for creating and
editing LEGO models, which we call Noctua. Noctua en-
ables web-based collaborative annotation of LEGO mod-
els. Currently the GOC is in the process of transitioning to
Noctua (http://noctua.berkeleybop.org) as the primary GO
curation tool. Several GO annotation providers are already
using the Noctua software to create LEGOmodels, and the
GOC expects the number and utility of such models to in-
crease rapidly in the coming period.We have conducted five
annotation workshops in the past year to introduce biocu-
rators to the Noctua annotation tool and the principles of
OWL-based LEGO curation. Documentation for LEGO
curation is linked from the Noctua home page, and is dy-
namically updated to reflect ongoing curatorial analysis and
dialogue.
SUMMARY
The Gene Ontology Consortium is a growing, multidisci-
plinary community spanning biology, medicine and com-
puter science. We aim to create a comprehensive, computa-
tional model of biological knowledge, that will continue to
support analysis and interpretation of the ever-increasing
store of molecular biomedical data. The endeavor is depen-
dent on continued evaluation of our current understanding
of biological systems, and has been strengthened and im-
proved through the contributions of a large number of bi-
ologists and software developers.
We invite the research community to offer their input
in all biological areas, as we strive to continuously im-
prove the quality of GO knowledgebase and tools. Research
groups may contribute updates to the ontology (e.g. re-
quest new terms) or provide new and updated annotations;
feedback on the usability of existing tools or data, or sug-
gestions for new features, are also welcome. Learn more
about how to contribute your work to the GO resource at
http://geneontology.org/page/contributing-go.
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